Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes

Journal of Bacteriology

Volumn 195, Issue 13, 2013, Pages 2959-2970

  Tanaka, Yukinori ^a   Kasahara, Ken ^b   Hirose, Yutaka ^b   Murakami, Kiriko ^b   Kugimiya, Rie ^b   Ochi, Kozo ^a  

^a HIROSHIMA INSTITUTE OF TECHNOLOGY   (Japan)

^b Neo Morgan Laboratory Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; CONTROLLED STUDY; GENE CLUSTER; GENE MUTATION; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES ANTIBIOTICUS; STREPTOMYCES COELICOLOR; STREPTOMYCES GRISEUS; STREPTOMYCES LAVENDULAE; TRANSCRIPTION INITIATION; VEILLONELLA PARVULA;

ACTINOBACTERIA; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MULTIGENE FAMILY; MUTATION; RIFAMPIN;

ACTINOBACTERIA (CLASS); AMYCOLATOPSIS; SACCHAROPOLYSPORA; STREPTOMYCES;

EID: 84880008648     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00147-13     Document Type: Article

References (50)

1. Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70:461-477.
2. Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417:141-147.
3. Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Omura S. 2003. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat. Biotechnol. 21:526-531.
4. Ohnishi Y, Ishikawa J, Hara H, Suzuki H, Ikenoya M, Ikeda H, Yamashita A, Hattori M, Horinouchi S. 2008. Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J. Bacteriol. 190:4050-4060.
5. Oliynyk M, Samborskyy M, Lester JB, Mironenko T, Scott N, Dickens S, Haydock SF, Leadlay PF. 2007. Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nat. Biotechnol. 25:447-453.
6. Clardy J, Fischbach MA, Walsh CT. 2006. New antibiotics from bacterial natural products. Nat. Biotechnol. 24:1541-1550.
7. Craney A, Ozimok C, Pimentel-Elardo SM, Capretta A, Nodwell JR. 2012. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem. Biol. 19:1020-1027.
8. Ochi K, Okamoto S. 2012. A magic bullet for antibiotic discovery. Chem. Biol. 19:932-934.
9. Hosaka T, Xu J, Ochi K. 2006. Increased expression of ribosome recycling factor is responsible for the enhanced protein synthesis during the late growth phase in an antibiotic-overproducing Streptomyces coelicolor ribosomal rpsL mutant. Mol. Microbiol. 61:883-897.
10. Nishimura K, Hosaka T, Tokuyama S, Okamoto S, Ochi K. 2007. Mutations in rsmG, encoding a 16S rRNA methyltransferase, result in low-level streptomycin resistance and antibiotic overproduction in Streptomyces coelicolor A3(2). J. Bacteriol. 189:3876-3883.
11. Tanaka Y, Komatsu M, Okamoto S, Tokuyama S, Kaji A, Ikeda H, Ochi K. 2009. Antibiotic overproduction by rpsL and rsmG mutants of various actinomycetes. Appl. Environ. Microbiol. 75:4919-4922.
12. Ochi K. 2007. From microbial differentiation to ribosome engineering. Biosci. Biotechnol. Biochem. 71:1373-1386.
13. Ochi K, Hosaka T. 2013. New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters. Appl. Microbiol. Biotechnol. 97:87-98.
14. Tamehiro N, Hosaka T, Xu J, Hu H, Otake N, Ochi K. 2003. Innovative approach for improvement of an antibiotic-overproducing industrial strain of Streptomyces albus. Appl. Environ. Microbiol. 69:6412-6417.
15. Hu H, Ochi K. 2001. Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations. Appl. Environ. Microbiol. 67:1885-1892.
16. Wang G, Hosaka T, Ochi K. 2008. Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Appl. Environ. Microbiol. 74:2834-2840.
17. Inaoka T, Takahashi K, Yada H, Yoshida M, Ochi K. 2004. RNA polymerase mutation activates the production of a dormant antibiotic 3,3'-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis. J. Biol. Chem. 279:3885-3892.
18. Hosaka T, Ohnishi-Kameyama M, Muramatsu H, Murakami K, Tsurumi Y, Kodani S, Yoshida M, Fujie A, Ochi K. 2009. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat. Biotechnol. 27:462-464.
19. Hu H, Zhang Q, Ochi K. 2002. Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase subunit) of Streptomyces lividans. J. Bacteriol. 184:3984-3991.
20. Derewacz DK, Goodwin CR, McNees CR, McLean JA, Bachmann BO. 2013. Antimicrobial drug resistance affects broad changes in metabolomic phenotype in addition to secondary metabolism. Proc. Natl. Acad. Sci. U. S. A. 110:2336-2341.
21. Ochi K. 1987. Metabolic initiation of differentiation and secondary metabolism by Streptomyces griseus: significance of the stringent response (ppGpp) and GTP content in relation to A factor. J. Bacteriol. 169:3608-3616.
22. Ochi K. 1974. Biosynthesis of formycin: role of certain amino acids in formycin biosynthesis. J. Antibiot. (Tokyo) 27:902-916.
23. Okamoto S, Lezhava A, Hosaka T, Okamoto-Hosoya Y, Ochi K. 2003. Enhanced expression of S-adenosylmethionine synthetase causes overproduction of actinorhodin in Streptomyces coelicolor A3(2). J. Bacteriol. 185:601-609.
24. Carata E, Peano C, Tredici SM, Ferrari F, Tala A, Corti G, Bicciato S, De Bellis G, Alifano P. 2009. Phenotypes and gene expression profiles of Saccharopolyspora erythraea rifampicin-resistant (rif) mutants affected in erythromycin production. Microb. Cell Fact. 8:18-32.
25. McIntyre JJ, Bull AT, Bunch AW. 1996. Vancomycin production in batch and continuous culture. Biotechnol. Bioeng. 49:412-420.
26. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. 2000. Practical Streptomyces genetics. John Innes Foundation Norwich, United Kingdom.
27. Tanaka Y, Hosaka T, Ochi K. 2010. Rare earth elements activate the secondary metabolite-biosynthetic gene clusters in Streptomyces coelicolor A3(2). J. Antibiot. (Tokyo) 63:477-481.
28. Ohnishi Y, Yamazaki H, Kato JY, Tomono A, Horinouchi S. 2005. AdpA, a central transcriptional regulator in the A-factor regulatory cascade that leads to morphological development and secondary metabolism in Streptomyces griseus. Biosci. Biotechnol. Biochem. 69:431-439.
29. Gramajo HC, Takano E, Bibb MJ. 1993. Stationary-phase production of the antibiotic actinorhodin in Streptomyces coelicolor A3(2) is transcriptionally regulated. Mol. Microbiol. 7:837-845.
30. Elliot MA, Bibb MJ, Buttner MJ, Leskiw BK. 2001. BldD is a direct regulator of key developmental genes in Streptomyces coelicolor A3(2). Mol. Microbiol. 40:257-269.
31. Tanaka Y, Tokuyama S, Ochi K. 2009. Activation of secondary metabolite-biosynthetic gene clusters by generating rsmG mutations in Streptomyces griseus. J. Antibiot. (Tokyo) 62:669-673.
32. Bystrykh LV, Fernandez-Moreno MA, Herrema JK, Malpartida F, Hopwood DA, Dijkhuizen L. 1996. Production of actinorhodin-related "blue pigments" by Streptomyces coelicolor A3(2). J. Bacteriol. 178:2238-2244.
33. Okamoto S, Taguchi T, Ochi K, Ichinose K. 2009. Biosynthesis of actinorhodin and related antibiotics: discovery of alternative routes for quinone formation encoded in the act gene cluster. Chem. Biol. 16:226-236.
34. Baltz RH. 2011. Strain improvement in actinomycetes in the postgenomic era. J. Ind. Microbiol. Biotechnol. 38:657-666.
35. Imai Y, Fujiwara T, Ochi K, Hosaka T. 2012. Development of the ability to produce secondary metabolites in Streptomyces through the acquisition of erythromycin resistance. J. Antibiot. (Tokyo) 65:323-326.
36. Retzlaff L, Distler J. 1995. The regulator of streptomycin gene expression, StrR, of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites. Mol. Microbiol. 18:151-162.
37. Katz L, Donadio S. 1995. Macrolides. Biotechnology 28:385-420.
38. Leadlay PF. 1997. Combinatorial approaches to polyketide biosynthesis. Curr. Opin. Chem. Biol. 1:162-168.
39. Chng C, Lum AM, Vroom JA, Kao CM. 2008. A key developmental regulator controls the synthesis of the antibiotic erythromycin in Saccharopolyspora erythraea. Proc. Natl. Acad. Sci. U. S. A. 105:11346-11351.
40. Lai C, Xu J, Tozawa Y, Okamoto-Hosoya Y, Yao X, Ochi K. 2002. Genetic and physiological characterization of rpoB mutations that activate antibiotic production in Streptomyces lividans. Microbiology 148:3365-3373.
41. Tala A, Wang G, Zemanova M, Okamoto S, Ochi K, Alifano P. 2009. Activation of dormant bacterial genes by Nonomuraea sp. strain ATCC 39727 mutant-type RNA polymerase. J. Bacteriol. 191:805-814.
42. Wang G, Tanaka Y, Ochi K. 2010. The G243D mutation (afsB mutation) in the principal sigma factor sigmaHrdB alters intracellular ppGpp level and antibiotic production in Streptomyces coelicolor A3(2). Microbiology 156:2384-2392.
43. Xu J, Tozawa Y, Lai C, Hayashi H, Ochi K. 2002. A rifampicin resistance mutation in the rpoB gene confers ppGpp-independent antibiotic production in Streptomyces coelicolor A3 (2). Mol. Genet. Genomics 268:179-189.
44. Maughan H, Galeano B, Nicholson WL. 2004. Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination. J. Bacteriol. 186: 2481-2486.
45. Hirooka K, Danjo Y, Hanano Y, Kunikane S, Matsuoka H, Tojo S, Fujita Y. 2009. Regulation of the Bacillus subtilis divergent yetL and yetM genes by a transcriptional repressor, YetL, in response to flavonoids. J. Bacteriol. 191:3685-3697.
46. Inaoka T, Ochi K. 2011. Scandium stimulates the production of amylase and bacilysin in Bacillus subtilis. Appl. Environ. Microbiol. 77:8181-8183.
47. Kawai K, Wang G, Okamoto S, Ochi K. 2007. The rare earth, scandium, causes antibiotic overproduction in Streptomyces spp. FEMS Microbiol. Lett. 274:311-315.
48. Wenzel SC, Muller R. 2009. The biosynthetic potential of myxobacteria and their impact in drug discovery. Curr. Opin. Drug Discov. Devel. 12: 220-230.
49. Fukuda K, Tamura T, Ito H, Yamamoto S, Ochi K, Inagaki K. 2010. Production improvement of antifungal, antitrypanosomal nucleoside sinefungin by rpoB mutation and optimization of resting cell system of Streptomyces incarnatus NRRL 8089. J. Biosci. Bioeng. 109:459-465.
50. Challis GL, Hopwood DA. 2003. Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc. Natl. Acad. Sci. U. S. A. 100:14555-14561.